Imago BioSciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 25 shareholders own 92.86% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
12.6%	BlackRock, Inc.	4,262,077	US$153.5m	4.82%	no data
11.5%	Frazier Life Sciences Management, LP	3,902,207	US$140.5m	31.3%	9.25%
8.9%	Omega Fund Management, LLC	3,018,737	US$108.7m	0%	28.99%
7.29%	Farallon Capital Management, L.L.C.	2,471,313	US$89.0m	0%	0.63%
7.27%	Citadel Advisors LLC	2,464,750	US$88.8m	-2.08%	0.11%
7%	Blackstone Life Sciences	2,375,037	US$85.5m	0%	51.47%
5.56%	T. Rowe Price Group, Inc.	1,885,112	US$67.9m	-1.83%	0.01%
4.58%	Emerald Advisers, LLC	1,553,597	US$55.9m	2.01%	1.48%
4.47%	Bristol-Myers Squibb Company	1,514,835	US$54.5m	0%	no data
3.65%	The Vanguard Group, Inc.	1,236,272	US$44.5m	22.7%	no data
3.52%	Amgen Ventures	1,193,047	US$43.0m	0%	26.59%
2.24%	Merck & Co., Inc.	758,614	US$27.3m	0%	no data
1.54%	StepStone Group Inc.	522,987	US$18.8m	0%	2.49%
1.48%	Hugh Rienhoff	501,702	US$18.1m	2.49%	no data
1.35%	Woodline Partners LP	457,136	US$16.5m	-32%	0.23%
1.32%	Geode Capital Management, LLC	447,383	US$16.1m	46%	no data
1.28%	M Ventures	434,432	US$15.6m	0%	35.18%
1.16%	State Street Global Advisors, Inc.	394,639	US$14.2m	13.2%	no data
1.06%	Matrix Capital Management Company, LP	361,000	US$13.0m	0%	0.25%
1.03%	FMR LLC	349,740	US$12.6m	-93.1%	no data
1.01%	Driehaus Capital Management LLC	343,846	US$12.4m	-2.5%	0.13%
0.98%	New York Life Investment Management LLC	331,728	US$11.9m	0%	0.09%
0.74%	Northern Trust Global Investments	249,723	US$9.0m	11%	no data
0.73%	Laura Eichorn	246,453	US$8.9m	18.6%	no data
0.64%	AllianceBernstein L.P.	217,797	US$7.8m	-8.9%	no data